Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-002863-28Phase 4Terminated
Phase 4, single-arm trial of cholestyramine in erythropoietic protoporphyria (EPP), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: Reduction in protoporphyrin levels. Started Aug 2007; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-002863-28.